-
Beijing Honglin Pharm.
-
GoeGoe Honglin BioPharm. (Jiangsu)
GoeGoe Honglin Pharm.
GoeGoe Honglin Pharmaceutical Co. is a technology-driven pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines. Guided by a commitment to quality, innovation, and patient care, we leverage advanced pharmaceutical technologies and manufacturing expertise across a diverse portfolio of medicines to improve access to reliable and affordable treatments.
GoeGoe Honglin Pharmaceutical Co. is a technology-driven pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines. Guided by a commitment to quality, innovation, and patient care, we leverage advanced pharmaceutical technologies and manufacturing expertise across a diverse portfolio of medicines to improve access to reliable and affordable treatments.
Cardiovascular Health
Metabolism & Endocrinology
Pain & Fever
Digestive Health
Cold & Flu
Allergy Care
Central Nervous System (CNS)
Building upon the foundational principles of ALZA's OROS technology, we apply our controlled-release formulation expertise to develop advanced drug delivery solutions.
Our multidisciplinary team develops high-barrier generic formulations. We hold 6 proprietary patents in controlled-release technologies, covering sustained-release pellets, enteric-coated systems, and bilayer osmotic tablets.
We integrate internationally sourced equipment, quality-controlled processes, and standardized facilities in Beijing and Jiangsu to support scalable production and reliable supply.
Address : Yanqi Economic Development Area, Huairou District, Beijing, China 101407
Telephone : +86-10-61669962
Fax : +86-10-61669841/43
E-mail : blfy@osihl.com
No. 111 Yangtze River Road, Zhenjiang Economic and Technological Development Zone, Zhenjiang City, Jiangsu Province, China 212132
Telephone : +86-511-88891188
Fax : +86-511-88908008
© 2025 GoeGoe Honglin Biopharmaceutical (Jiangsu) Co., Ltd. All Rights Reserved. 
苏公网安备32110102321813号 苏ICP备2025220962号-1
Nifedipine Controlled-release Tablets
Nifedipine
1. Vasospastic Angina
2. Chronic Stable Angina (Classical Effort-Associated Angina)
3. Hypertension
Included in the National Essential Medicines List and classified as Category A of National Medical Insurance; it boasts a large market scale.
Adopts a double-layer osmotic pump controlled-release formulation and is supported by national patent technology, enabling stable blood pressure reduction, minimal side effects, and greater convenience with once-daily administration.
Produced using European and American imported equipment, featuring mature manufacturing processes, large batch production, high product quality, and sufficient production capacity.
Has passed the Consistency Evaluation of Generic Drugs, ensuring its quality and therapeutic effect are consistent with the original research drug.
GoeGoe Honglin(Jiangsu)
Beijing Honglin
GoeGoe Honglin Pharm.